27-29 April 2027
Congress Center HamburgHamburg, Germany Valerie SchmiederSenior Scientist (CMC Development Biologicals; Drug Substance Biologicals; Cell Line and Upstream Development) at Boehringer IngelheimSpeaker
Profile
Valerie Schmieder-Todtenhaupt, Ph.D., is a Senior Scientist in Cell Line Development at Boehringer Ingelheim. Her work focuses on the development of biologics, including monoclonal antibodies and complex derivates thereof, as well as the advancement of CHO platform technologies. Since joining Boehringer Ingelheim in 2018 as a Postdoctoral Scientist, she has contributed to cell line engineering, gene knockout technologies, and host cell protein reduction strategies. Prior to her current role, she worked in Upstream Process Development, supporting the development of clinical and commercial bioprocesses.
Agenda Sessions
De-Risking Purification Upstream of Downstream: Eliminating Polysorbate-Degrading Enzymes Through CHO Cell Line and Process Engineering
, 09:30View Session